According to Rallybio's latest financial reports the company's current EPS (TTM) is -HK$15.15. In 2022 the company made an earnings per share (EPS) of -HK$16.39 a decrease over its 2021 EPS that were of -HK$13.59.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$15.29 | -6.76% |
2022 | -HK$16.39 | 20.67% |
2021 | -HK$13.59 | 47.08% |
2020 | -HK$9.24 |